Stocktoria
Zivo Bioscience, Inc. ZIVO
OTC · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2000-10-06
Zivo Bioscience, Inc. statistics & valuation
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 31.1% | 42.0% | — | — | — | — | — | — | — | — |
| Operating margin | -8498.9% | -26267.7% | — | — | -42778.4% | — | — | — | — | — |
| Net margin | -8513.4% | -28127.2% | — | — | -45528.6% | — | — | — | — | — |
| Return on assets | -814.6% | -1399.5% | -411.9% | -97.4% | -4135.6% | -3116.0% | -3556.5% | -3021.1% | -821.9% | -7965.2% |
| Return on equity | 2599.5% | 352.6% | 82331.9% | -144.9% | 80.5% | 138.0% | 65.7% | 61.6% | 44.5% | 61.0% |
| Current ratio | 0.80 | 0.15 | 0.94 | 3.04 | 0.01 | 0.04 | 0.02 | 0.07 | 0.05 | 0.01 |
Source: SEC EDGAR filings · CIK 0001101026 · US · as of 2024-12-31. facts plus Stocktoria's own computed scores — not investment advice.